KyleZanoccoMD

PubMed

• A call for community-shared decisions.
  Jason N Doctor, Daniella Meeker, Craig R Fox, Stephen D Persell, Zachary Wagner, Kathryn E Bouskill, Robert J Romanelli, Chad M Brummett, Allison Kirkegaard, Katherine...> ;BMJ Evidence-Based Medicine. 2024 Apr 10
• Peer Comparison or Guideline-Based Feedback and Postsurgery Opioid Prescriptions: A Randomized Clinical Trial.
  Zachary Wagner, Allison Kirkegaard, Louis T Mariano, Jason N Doctor, Xiaowei Yan, Stephen D Persell, Noah J Goldstein, Craig R Fox, Chad M Brummett, Robert J Romanelli...> ;JAMA Health Forum. 2024 Mar 1
• Challenges and controversies in adrenal surgery: A practical approach.
  Toni Beninato, Quan-Yang Duh, Kristin L Long, Colleen M Kiernan, Barbra S Miller, Snehal Patel, Reese W Randle, Heather Wachtel, Kyle A Zanocco, Nicole K Zern, Frederi...> ;Current Problems in Surgery. 2023 Sep 1
• Disparities in postoperative opioid prescribing by race and ethnicity: an electronic health records-based observational study from Northern California, 2015-2020.
  Robert J Romanelli, Rivfka Shenoy, Meghan C Martinez, Satish Mudiganti, Louis T Mariano, Kyle A Zanocco, Zachary Wagner, Allison Kirkegaard, Katherine E Watkins> ;Archives of Public Health = Archives Belges De Sante Publique. 2023 May 6
• The Patient Experience of Thyroid Cancer.
  Susan C Pitt, Kyle Zanocco, Cord Sturgeon> ;Endocrinology and Metabolism Clinics of North America. 2022 Dec 1
• 3 citations
  Perception of risk and treatment decisions in the management of differentiated thyroid cancer.
  Max A Schumm, Michelle L Shu, Jiyoon Kim, Chi-Hong Tseng, Kyle Zanocco, Masha J Livhits, Angela M Leung, Michael W Yeh, Greg D Sacks, James X Wu> ;Journal of Surgical Oncology. 2022 Aug 1
• 9 citations
  Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
  Rivfka Shenoy, Zachary Wagner, Allison Kirkegaard, Robert J Romanelli, Satish Mudiganti, Louis Mariano, Meghan Martinez, Kyle Zanocco, Katherine E Watkins> ;JAMA Health Forum. 2021 Oct 1
• 7 citations
  Cost analysis of reflexive versus selective molecular testing for indeterminate thyroid nodules.
  Q. Lina Hu, Max A. Schumm, Kyle Zanocco, Michael W. Yeh, Masha J. Livhits, James X. Wu> ;Surgery. 2021 Jul 17
• 3 citations
  Measuring patient perceptions of surgeon communication performance in the treatment of thyroid nodules and thyroid cancer using the communication assessment tool.
  Max A. Schumm, Roben Ohev-Shalom, Dalena T Nguyen, Jiyoon Kim, Chi-Hong Tseng, Kyle Zanocco> ;Surgery. 2021 Feb 1
• 8 citations
  Patient experience with electronic health record-integrated postoperative telemedicine visits in an academic endocrine surgery program.
  Max A. Schumm, Howard Q Pyo, Roben Ohev-Shalom, Chi-Hong Tseng, Masha J. Livhits, Kyle Zanocco, Darryl T. Hiyama, Michael W. Yeh> ;Surgery. 2021 May 1
• 4 citations
  Cost Saving of Short Hospitalization Nonoperative Management for Acute Uncomplicated Appendicitis.
  Max A. Schumm, Christopher P. Childers, James X. Wu, Kyle Zanocco> ;The Journal of Surgical Research. 2020 Nov 1
• 13 citations
  Selective use of Molecular Testing Based on Sonographic Features of Cytologically Indeterminate Thyroid Nodules: A Decision Analysis
  Kyle Zanocco, Max M Wang, Michael W. Yeh, Masha J. Livhits> ;World Journal of Surgery. 2020 Feb 1
• Re: Cost effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules.
  M Shreyamsa, V Sasi Mouli, Kul Ranjan Singh, Pooja Ramakant, Anand Kumar Mishra> ;Surgery. 2019 Nov 1
• 3 citations
  Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism
  John J. Nguyen-Lee, Mario Paciuc, Rudy Guerra, Nestor F. Esnaola, Kyle Zanocco, Feibi Zheng> ;Surgery. 2020 Jan 1
• 23 citations
  Active Surveillance of Low-Risk Thyroid Cancer.
  Kyle Zanocco, Jerome M. Hershman, Angela M. Leung> ;JAMA. 2019 May 28
• Response to "Re: Cost-effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules".
  Eric J Kuo, James X Wu, Kyle A Zanocco> ;Surgery. 2019 Mar 1
• Re: Cost-effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules.
  Franklin N. Tessler, William D. Middleton, Edward Grant, Jenny K. Hoang> ;Surgery. 2019 Mar 1
• Comments on: Cost-effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules.
  Sarada Khadka, Kavindra Singh, Chitresh Kumar> ;Surgery. 2019 Feb 1
• Response to "Comments on: Cost effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules".
  Eric J Kuo, James X Wu, Kyle A Zanocco> ;Surgery. 2019 Feb 1
• 1 citations
  ASO Author Reflections: Preoperative Risk Stratification in Differentiated Thyroid Cancer.
  Kyle Zanocco> ;Annals of Surgical Oncology. 2018 Nov 12
• 12 citations
  Cost effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules
  Eric J. Kuo, James X. Wu, Kyle Zanocco> ;Surgery. 2018 Dec 1
• 35 citations
  Gene Expression Classifier vs Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules.
  Masha J. Livhits, Eric J. Kuo, Angela M. Leung, Jianyu Rao, Mary Levin, Michael Douek, Katrina Beckett, Kyle Zanocco, Dianne S Cheung, Yaroslav A Gofnung, Stephanie Sm...> ;The Journal of Clinical Endocrinology and Metabolism. 2018 Jun 1
• 9 citations
  Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer.
  Kyle Zanocco, David J. Kaltman, James X. Wu, Abbey L. Fingeret, Keith S. Heller, James A. Lee, Michael W. Yeh, Julie Ann Sosa, Cord Sturgeon> ;Annals of Surgical Oncology. 2018 Feb 7
• 29 citations
  Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension.
  Eric J. Kuo, William J. Thi, Feibi Zheng, Kyle Zanocco, Masha J. Livhits, Michael W. Yeh> ;Thyroid. 2017 Dec 1
• 52 citations
  Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
  Eric J. Kuo, Shonan Sho, Ning Li, Kyle Zanocco, Michael W. Yeh, Masha J. Livhits> ;JAMA Surgery. 2017 Sep 27
• Join now to see all

Journal Articles

• The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: A cost analysis  
  Morris LF, Zanocco K, Ituarte PH, Ro K, Duh QY, Sturgeon C, Yeh MW, Annals of Surgical Oncology, 1/1/2010

Books/Book Chapters

• Handbook of Parathyroid Diseases 
  Chapter: Cost-effectiveness of parathyroidectomy for primary hyperparathyroidism. 
  Page 271 - 276Zanocco K, Sturgeon CEditors: Khan A and Clark O.Springer, New York, NY2012
• Contemporary Vascular Surgery 
  Chapter: Laparoscopic median arcuate ligament release. 
  Page 481 - 490Zanocco K, Hungness EEditors: Eskandari M, Morasch M, Pearce W, Yao J.People's Medical Publishing House, Shelton, CT2011

Abstracts/Posters

• Dexterity assessment in primary hyperparathyroidism using the 9-Hole pegboard test.
  Kaltman D, Zanocco K, Elaraj D, Sturgeon C, Journal of Surgical Research, 1/1/2014
• Measurement of patient-reported outcomes in primary hyperparathyroidism before and after parathyroidectomy.
  Zanocco K, Elaraj D, Sturgeon C, 19th Annual Agency for Healthcare Research and Quality National Research Service Award Trainees Conference, Baltimore, MD, 1/1/2013
• On-site adequacy evaluation is not cost-effective for experienced operators performing initial ultrasound-guided fine needle aspiration of thyroid nodules.
  Zanocco K, Pitelka-Zengou L, Dalal S, Elaraj D, Nayar N, Sturgeon C, Thyroid, 1/1/2012
• The cost-effectiveness of recombinant human thyroid stimulating hormone administration prior to remnant ablation for treatment of differentiated thyroid cancer.
  Zanocco K, Sturgeon C., Journal of Surgical Research, 1/1/2012
• Cost analysis of thyroid fine needle aspiration on-site evaluation.
  Pitelka-Zengou L, Zanocco K, Dalal S, Sturgeon C, Nayar R, Modern Pathology, 1/1/2012
• On-site adequacy evaluation is not cost-effective for experienced operators performing initial ultrasound-guided fine needle aspiration of thyroid nodules.
  Zanocco K, Pitelka-Zengou L, Dalal S, Elaraj D, Nayar N, Sturgeon C, American Thyroid Association Annual Meeting, Quebec City, QC, Canada, 1/1/2012
• Cost analysis of thyroid fine needle aspiration on-site evaluation.
  Pitelka-Zengou L, Zanocco K, Dalal S, Sturgeon C, Nayar R, United States and Canadian Academy of Pathology Annual Meeting, Vancouver, BC, Canada, 1/1/2012
• Cost-effectiveness analysis of repeat FNA for thyroid biopsies read as atypia of undetermined significance.
  Heller M, Zanocco K, Zydowicz S, Elaraj D, Nayar R, Sturgeon C, Journal of Surgical Research, 1/1/2011
• Is subtotal thyroidectomy a cost-effective treatment for Graves' disease?
  Zanocco K, Heller M, Elaraj D, Sturgeon C, Journal of Surgical Research, 1/1/2011
• What are the optimal parameters for a test that would improve the diagnostic accuracy for indeterminate thyroid nodules? A cost-effectiveness analysis.
  Zanocco K, Elaraj D, Sturgeon C, Journal of the American College of Surgeons, 1/1/2009
• Screening all patients with the aldosterone to renin ratio is economically sound.
  Lee J, Zarnegar R, Russo M, Zanocco K, Ahmed L, Allendorf J, Chabot J, Inabnet W, International Association of Endocrine Surgeons, Montreal, QC, Canada, 1/1/2007
• Cost-effectiveness analysis of the medical and surgical treatment options for Graves' disease.
  Zanocco K, Sturgeon C, Angelos P, Journal of the American College of Surgeons, 1/1/2006
• Join now to see all

Lectures

• Molecular Testing of Cytologically Indeterminate Thyroid Nodules: Performance, Clinical Utility, and Value 
  Chicago, IL - 1/14/2015
• Improvement in Patient-Reported Outcomes Following Parathyroidectomy for Primary Hyperparathyroidism. 
  Las Vegas, NV - 1/1/2014
• Patient-reported outcomes and quality of life in primary hyperparathyroidism 
  Chicago, IL - 1/2/2013
• Routine prophylactic central lymph node dissection for low-risk papillary thyroid cancer: A cost-effectiveness analysis. 
  Chicago, IL - 1/1/2013
• Cost and quality of life thresholds that determine the cost-effectiveness of scarless thyroidectomy. 
  New Orleans, LA - 1/1/2013
• Quality-adjusted life expectancy, Markov modeling, and Monte Carlo simulation in surgical outcomes research 
  Chicago, IL - 1/27/2012
• Using decision analysis to develop optimal strategies in the diagnosis and treatment of differentiated thyroid cancer 
  Chicago, IL - 1/15/2012
• The cost-effectiveness of recombinant human thyroid stimulating hormone administration prior to remnant ablation for treatment of differentiated thyroid cancer. 
  Las Vegas, NV - 1/1/2012
• Billing and documentation for office ultrasound and fine-needle aspiration 
  San Francisco, CA - 1/24/2011
• Computer adaptive testing for measurement of patient-reported outcomes in endocrine surgery 
  Chicago, IL - 1/15/2011
• Using targeted cost feedback to reduce intraoperative waste 
  Chicago, IL - 1/8/2011
• Is subtotal thyroidectomy a cost-effective treatment for Graves' disease? 
  Huntington Beach, CA - 1/1/2011
• What are the optimal parameters for a test that would improve the diagnostic accuracy for indeterminate thyroid nodules? A cost-effectiveness analysis. 
  Chicago, IL - 1/1/2009
• Cost-effectiveness analysis of intraoperative frozen section examination for unilateral indeterminate thyroid lesions. 
  Huntington Beach, CA - 1/1/2008
• How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? A cost-effectiveness analysis. 
  Huntington Beach, CA - 1/1/2008
• Cost-effectiveness analysis of the medical and surgical treatment options for Graves' disease. 
  Chicago, IL - 1/1/2006
• Cost-effectiveness analysis of minimally invasive parathyroidectomy for asymptomatic primary hyperparathyroidism. 
  New York, NY - 1/1/2006
• Join now to see all

Other

• Billing and documentation for office ultrasound and fine-needle aspiration 
  Zanocco K, Course Syllabus, American College of Surgeons Postgraduate Course 20: Modern Evidence-Based Manageme
  1/7/2011
• The surgical treatment options for Graves' disease 
  Zanocco K, Sturgeon C, Newsletter of the National Graves' Disease Foundation
  1/1/2005